Talk to the Institute
Published mark

JUPITER NEUROSCIENCES, INC.

NASDAQ: JUNS. Canonical company identity and public leadership record.

US

Record source reportedRecord not claimedNo Eval published
Follow companySave PDF
Alpha ID
alpha:company:ac3605f1-4b07-4324-a5de-75558929c790
SEC CIK
0001679628
Record version
vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce, published Oct 18, 2026
Newest evidence
Apr 1, 2026
Monitoring
Not yet monitored Details
Integrity
Not yet signed Methodology
CEO
Christer RosénSince Apr 1, 2026
Chair
Not published
Independent
3 / 66 directors published
Published claims
253 distinct sources
Evidence records
80 pinned
Source conflicts
0None open

Built from 3 distinct sources and 8 evidence records. Every Claim links to where it appears. Where nothing was published, the record states the coverage gap.

CorroboratedSource reportedAlpha inferenceNot disclosed

Public record. Alpha publishes governance facts about this organization from regulatory filings and company statements. Private enterprise overlay data is never projected here. The company can claim the record, correct, or dispute any Claim. How this works

EXECUTIVE APPOINTED

Alexander Rosén executive of JUPITER NEUROSCIENCES, INC., effective 2026-04-01.

EffectiveEffective Apr 1, 2026E3

Monitoring

Continuous

What the published record states about identity, evidence, evaluation, monitoring, authority, and freshness. Watched-source schedules are not published for this record.

  • Identityunclaimed
    Published
  • Evidencesource_reported
    Published
  • Evaluationnot_evaluated
    Published
  • MonitoringNot yet published for this record.
    Not published
  • AuthorityNot yet published for this record.
    Not published
  • Freshnesscurrent
    Published

Leadership

Evidence
RolePersonSinceStatusClaim
Chief Administrative OfficerAlexander RosénApr 2026currentSource reportedE3
President, Chief Business Officer, and DirectorAlison D. SilvaApr 2026currentSource reportedE4
Chairman of Board, Chief Executive Officer and DirectorChrister RosénApr 2026currentSource reportedE5
Chief Scientific Officer and DirectorMarshall Hayward, Ph.D.Apr 2026currentSource reportedE6
Chief Financial Officer and SecretarySaleem ElmasriApr 2026currentSource reportedE7

Board of directors

Evidence

6 directors published. 3 of 6 with a published determination are independent.

DirectorStatusSinceCommitteesClaim
Alison D. SilvaNot independent2018None publishedSource reportedE2
Christer RosénNot independent2016None publishedSource reportedE2
Holger WeisIndependent2021Audit, chairAudit · Chair; Nominating and GovernanceNominating and GovernanceSource reportedE2
Julie KampfIndependent2021CompensationCompensation; Nominating and Governance · ChairNominating and Governance, chairSource reportedE2
Marshall Hayward, Ph.D.Not independent2016None publishedSource reportedE2
Nicholas HemmerlyIndependent2021AuditAudit; Compensation · Chair; Nominating and GovernanceCompensation, chairNominating and GovernanceSource reportedE2

Committees and risk ownership

Evidence
CommitteeChairMembersRisks assigned
AuditHolger WeisHolger Weis, Nicholas HemmerlyNot described in the published record
Audit · Chair; Nominating and GovernanceNot publishedHolger WeisNot described in the published record
Audit; Compensation · Chair; Nominating and GovernanceNot publishedNicholas HemmerlyNot described in the published record
CompensationNicholas HemmerlyNicholas Hemmerly, Julie KampfNot described in the published record
Compensation; Nominating and Governance · ChairNot publishedJulie KampfNot described in the published record
Nominating and GovernanceJulie KampfJulie Kampf, Holger Weis, Nicholas HemmerlyNot described in the published record
Committee RecordAudit: Chair Holger Weis; Members Holger Weis (Chair); Nicholas Hemmerly
Source reportedE8
company:ac3605f1-4b07-4324-a5de-75558929c790:committee_record:16
Committee AppointmentHolger Weis: chair, Audit
Source reportedE8
company:ac3605f1-4b07-4324-a5de-75558929c790:committee_appointment:17
Committee AppointmentNicholas Hemmerly: member, Audit
Source reportedE8
company:ac3605f1-4b07-4324-a5de-75558929c790:committee_appointment:18
Committee RecordCompensation: Chair Nicholas Hemmerly; Members Nicholas Hemmerly (Chair); Julie Kampf
Source reportedE8
company:ac3605f1-4b07-4324-a5de-75558929c790:committee_record:19
Committee AppointmentNicholas Hemmerly: chair, Compensation
Source reportedE8
company:ac3605f1-4b07-4324-a5de-75558929c790:committee_appointment:20
Committee AppointmentJulie Kampf: member, Compensation
Source reportedE8
company:ac3605f1-4b07-4324-a5de-75558929c790:committee_appointment:21
Committee RecordNominating and Governance: Chair Julie Kampf; Members Julie Kampf (Chair); Holger Weis; Nicholas Hemmerly
Source reportedE8
company:ac3605f1-4b07-4324-a5de-75558929c790:committee_record:22
Committee AppointmentJulie Kampf: chair, Nominating and Governance
Source reportedE8
company:ac3605f1-4b07-4324-a5de-75558929c790:committee_appointment:23
Committee AppointmentHolger Weis: member, Nominating and Governance
Source reportedE8
company:ac3605f1-4b07-4324-a5de-75558929c790:committee_appointment:24
Committee AppointmentNicholas Hemmerly: member, Nominating and Governance
Source reportedE8
company:ac3605f1-4b07-4324-a5de-75558929c790:committee_appointment:25

Control and voting power

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Authority to act

Evidence and agent registry

Who can act for the company, and on whose authority. This is what a counterparty's agent checks before it accepts an order, signs, or pays.

Principal executive officerChrister Rosén, Chairman of Board, Chief Executive Officer and Director, from Apr 1, 2026
Source reportedE5
company:ac3605f1-4b07-4324-a5de-75558929c790:leadership_role:13
Who can authorize an agentNot assessedNo Alpha inference about signing authority or board-reserved matters is published for this record.
Not assessed
bind
AI agents registered by the companyNot registered in the public RegistryAgent Deployments, Agent Use Cases, Authority Grants, TrustChecks, Action Ledger entries and Governance Receipts live in the private enterprise overlay. They are never projected into the public Registry without explicit cross-plane authorization. Absence here is a plane boundary, not evidence that the enterprise operates no agents.
Agent registry
agents
Delegations publishedNot disclosedBoard and officer delegation resolutions are not public filings and are not published in this record.
Search scope
delegations

Financials and market context

Evidence
Security ListingJUNS (NASDAQ)
Source reportedE1
company:ac3605f1-4b07-4324-a5de-75558929c790:security_listing:26
Index membershipsNo current membership is published in Alpha's tracked index universe.This is not evidence that the company is absent from every market index.
None publishedAs of Oct 18, 2026. Rights-filtered public evidence only; no redistribution or model training is granted. Only source-backed memberships with an explicit public redistribution basis are returned.

Governance and policies

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Risk, audit, and cyber

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

AI oversight and accountability

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Compensation

Evidence

No published claims

Nothing is published for this section yet. A missing Claim is a coverage state, not a negative finding.

Other published claims

Evidence

Published Claims that belong to no section above. Each keeps its permalink, evidence, and assertion state.

Legal NameJUPITER NEUROSCIENCES, INC.
Source reportedE1
company:ac3605f1-4b07-4324-a5de-75558929c790:legal_name:1
Entity StatusPublic listing published
Source reportedE1
company:ac3605f1-4b07-4324-a5de-75558929c790:entity_status:3

Not yet in this record

Coverage

A gap is a coverage state, not a negative finding. These sections are expected for this entity class and are not yet published.

  • Corporate structureNot reviewed. Parent, subsidiary and predecessor structure explains who is governed.
  • OwnershipNot reviewed. Ownership and voting power determine who can influence the board.
  • FinancialsNot reviewed. Governance-relevant financial context frames capital and audit decisions.
  • CompensationNot reviewed. Pay design shows how incentives are governed.
  • GovernanceNot reviewed. Governing documents and provisions set the rules of the enterprise.
  • Shareholder governanceNot reviewed. Meeting and vote records show shareholder dissent and support.
  • AuditNot reviewed. Auditor, controls and restatements show assurance over reporting.
  • LegalNot reviewed. Material legal and regulatory matters show enforcement exposure.
  • RiskNot reviewed. Risk ownership links the board, committees, executives and controls.
  • CyberNot reviewed. Cyber and data governance is a disclosed oversight domain.
  • AI governanceNot reviewed. AI oversight is a differentiated Alpha governance domain.
  • Markets externalNot reviewed. Auditors, advisors, investors and regulators form the external ecosystem.
  • Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
  • Only explicitly published canonical company identity and current confirmed public roles are included.Only explicitly published canonical company identity and current confirmed public roles are included.
  • Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
  • Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
  • This Company Profile is an identity and evidence record, not an Alpha rating.This Company Profile is an identity and evidence record, not an Alpha rating.

Subject and corrections

Public-role doctrine

This record exists because the company is in the published Registry. The company can claim the record, correct, or dispute any Claim. Corrections are versioned and the original stays in history.

Basis
Published company record built from public sources
Sources
8 evidence records cited. 0 with redistribution rights.
Never published
Private enterprise overlay data: deployments, authority grants, TrustChecks, receipts, telemetry
Record claimed
No
Open disputes
0
Identity ownership
unclaimed
Claiming not yet available

If the company claims the record, its statements appear as their own assertion state and never overwrite the cited evidence.

Evidence

Authority and rights
  1. E1
    Alpha canonical company public projection
    Alpha canonical company public projection. canonical identity. Retrieved Oct 18, 2026. Cited by 4 Claims.
    Open web
    Rights not recorded, link only
    Evidence not pinned
  2. E2
    JUPITER NEUROSCIENCES, INC. DEF 14A 2025-11-06
    sec proxy. Published Nov 6, 2025. Retrieved Apr 25, 2026. Cited by 6 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  3. E3
    JUNS 10-K executive officers
    sec filing. Published Apr 1, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  4. E4
    JUNS 10-K executive officers
    sec filing. Published Apr 1, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  5. E5
    JUNS 10-K executive officers
    sec filing. Published Apr 1, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  6. E6
    JUNS 10-K executive officers
    sec filing. Published Apr 1, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  7. E7
    JUNS 10-K executive officers
    sec filing. Published Apr 1, 2026. Retrieved May 16, 2026. Cited by 1 Claim.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned
  8. E8
    Audit
    board_seats. board seats. Cited by 10 Claims.
    Authoritative, regulatory filing
    Rights not recorded, link only
    Evidence not pinned

What changed in version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

vpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce published Oct 18, 2026
  • Alexander Rosén executive of JUPITER NEUROSCIENCES, INC., effective 2026-04-01.
  • Alison D. Silva executive of JUPITER NEUROSCIENCES, INC., effective 2026-04-01.
  • Christer Rosén executive of JUPITER NEUROSCIENCES, INC., effective 2026-04-01.
  • Marshall Hayward, Ph.D. executive of JUPITER NEUROSCIENCES, INC., effective 2026-04-01.
  • Saleem Elmasri executive of JUPITER NEUROSCIENCES, INC., effective 2026-04-01.
  • Holger Weis seat on JUPITER NEUROSCIENCES, INC., effective 2021-01-01.
  • Julie Kampf seat on JUPITER NEUROSCIENCES, INC., effective 2021-01-01.
  • Nicholas Hemmerly seat on JUPITER NEUROSCIENCES, INC., effective 2021-01-01.
  • Audit · Chair; Nominating and Governance committee of JUPITER NEUROSCIENCES, INC., effective 2021-01-01.
  • Holger Weis member of Audit · Chair; Nominating and Governance, effective 2021-01-01.
  • Audit; Compensation · Chair; Nominating and Governance committee of JUPITER NEUROSCIENCES, INC., effective 2021-01-01.
  • Nicholas Hemmerly member of Audit; Compensation · Chair; Nominating and Governance, effective 2021-01-01.
  • Compensation; Nominating and Governance · Chair committee of JUPITER NEUROSCIENCES, INC., effective 2021-01-01.
  • Julie Kampf member of Compensation; Nominating and Governance · Chair, effective 2021-01-01.
  • Alison D. Silva seat on JUPITER NEUROSCIENCES, INC., effective 2018-01-01.
  • Christer Rosén seat on JUPITER NEUROSCIENCES, INC., effective 2016-01-01.
  • Marshall Hayward, Ph.D. seat on JUPITER NEUROSCIENCES, INC., effective 2016-01-01.
Appearance

Alpha Governance PBC. The Registry records reported facts and Alpha's assessments separately. A missing fact is not evidence that it is false.

Record alpha:company:ac3605f1-4b07-4324-a5de-75558929c790, version public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce. https://registry.alpha.ac/companies/jupiter-neurosciences-inc

Navigate

On this record

  1. Overview
  2. Monitoring4
  3. Leadership5
  4. Board6
  5. Committees6
  6. Control and voting0
  7. Authority to act4
  8. Financials1
  9. Governance0
  10. Risk0
  11. AI oversight0
  12. Legal0
  13. Compensation0
  14. Other published claims3
  15. Coverage gaps17
  16. Linked people8
  17. Subject and corrections6
  18. Evidence8
  19. Version historyvpublic-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce

Linked records

Registry

Appearance

esc
  • Actions
    Switch to agent viewJSON, Markdown, MCP
  • Copy Alpha IDalpha:company:ac3605f1-4b07-4324-a5de-75558929c790
  • Cite this recordJUPITER NEUROSCIENCES, INC.
  • Copy canonical URLregistry.alpha.ac/companies/jupiter-neurosciences-inc
  • Copy as MarkdownWith assertion states
  • Report an error
  • Theme: System
  • Theme: Light
  • Theme: Dark
  • Records
    JUPITER NEUROSCIENCES, INC.Company
  • Alexander RosénPerson
  • Alison D. SilvaPerson
  • Christer RosénPerson
  • Marshall Hayward, Ph.D.Person
  • Saleem ElmasriPerson
  • Holger WeisPerson
  • Julie KampfPerson
  • Nicholas HemmerlyPerson
  • Sections
    OverviewJUPITER NEUROSCIENCES, INC.
  • MonitoringJUPITER NEUROSCIENCES, INC.
  • LeadershipJUPITER NEUROSCIENCES, INC.
  • BoardJUPITER NEUROSCIENCES, INC.
  • CommitteesJUPITER NEUROSCIENCES, INC.
  • Control and votingJUPITER NEUROSCIENCES, INC.
  • Authority to actJUPITER NEUROSCIENCES, INC.
  • FinancialsJUPITER NEUROSCIENCES, INC.
  • GovernanceJUPITER NEUROSCIENCES, INC.
  • RiskJUPITER NEUROSCIENCES, INC.
  • AI oversightJUPITER NEUROSCIENCES, INC.
  • LegalJUPITER NEUROSCIENCES, INC.
  • CompensationJUPITER NEUROSCIENCES, INC.
  • Other published claimsJUPITER NEUROSCIENCES, INC.
  • Coverage gapsJUPITER NEUROSCIENCES, INC.
  • Linked peopleJUPITER NEUROSCIENCES, INC.
  • Subject and correctionsJUPITER NEUROSCIENCES, INC.
  • EvidenceJUPITER NEUROSCIENCES, INC.
  • Version historyJUPITER NEUROSCIENCES, INC.
↑ ↓ move↵ openThis record only

Report an error

Reports attach to the Claim and go to an Alpha analyst through the correction form. Corrections are versioned, and the original stays in history.